Gefitinib-resistance is related to BIM expression in non-small cell lung cancer cell lines

Ähnliche Einträge

• Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial
  von: Douillard, Jean-Yves, et al.
  Veröffentlicht: (2010)
• MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines
  Veröffentlicht: (2012)
• Upregulation of bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines
  von: Sartorius, Ute, et al.
  Veröffentlicht: (2002)
• First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
  von: Carbone, David P., et al.
  Veröffentlicht: (2017)
• EGFR-TKI resistant non-small cell lung cancer (NSCLC): new developments and implications for future treatment
  von: Brugger, Wolfram, et al.
  Veröffentlicht: (2012)